Searches for "Ozempic alternative" and "Mounjaro alternative" spike constantly, and a lot of that traffic is actually looking for the research compounds behind those brand names, semaglutide and tirzepatide, not a prescription substitute. This guide is written for that second group: researchers who want unformulated, research-grade semaglutide or tirzepatide for laboratory work, and need to know what separates the two compounds and what to check before sourcing either one.
Ozempic and Mounjaro are brand names, not the research compounds
Ozempic, Wegovy, and Rybelsus are FDA-approved prescription products made by Novo Nordisk; their active ingredient is semaglutide. Mounjaro and Zepbound are FDA-approved prescription products made by Eli Lilly; their active ingredient is tirzepatide. V8 Peptides has no affiliation with either manufacturer, does not sell those branded medications, and does not offer a substitute for them. What V8 supplies is the unformulated peptide itself, semaglutide or tirzepatide, as a lyophilized research reagent for laboratory use only, not for human consumption or clinical use of any kind. The brand names are referenced here only so researchers searching by the terminology they already know can find the correct compound pages.
Semaglutide vs. tirzepatide: which compound for which research
The two compounds are structurally and mechanistically distinct, and the difference matters for study design. Semaglutide is a single-receptor GLP-1 agonist, binding one target. Tirzepatide is a dual agonist, engineered to activate both the GLP-1 receptor and the GIP receptor at once, which is the basis for most of the comparative preclinical interest between the two. See semaglutide vs. tirzepatide for the full mechanism comparison, and GLP-1 receptor agonists in research for how both fit into the broader incretin-agonist class.
What to check before sourcing either compound
- Measured purity — a specific HPLC value, not a bare label claim. See HPLC purity analysis.
- Batch-specific Certificate of Analysis tied to the exact lot shipped. See how to read a COA.
- Independent third-party testing, not solely an in-house claim. See third-party testing explained.
- Correct peptide identity confirmed by mass spec, since semaglutide and tirzepatide are different-length chains that can look deceptively similar on a basic HPLC trace to an inexperienced eye.
- Research-use-only labeling with accurate reconstitution and storage documentation, not vague instructions.
For a broader rundown of what separates a documented supplier from an undocumented one, see choosing a peptide supplier.
Pricing: why tirzepatide costs more than semaglutide
Tirzepatide is a longer chain with an added fatty-acid conjugation step, which means more synthesis runs and more purification work to hit the same purity grade. That difference in production complexity is reflected in the price gap between the two compounds. See tirzepatide pricing: what drives the cost for the full breakdown.
Reconstitution and handling
Both compounds ship lyophilized and require reconstitution with bacteriostatic water before use in a research protocol. Concentration math, storage temperature, and stability windows differ slightly between the two. See semaglutide reconstitution & handling and tirzepatide reconstitution & handling for compound-specific guidance. V8 stocks bacteriostatic water alongside both compounds for labs that need it.
Where to buy research-grade semaglutide and tirzepatide
V8 Peptides supplies both compounds as lyophilized powder with a batch-specific Certificate of Analysis and HPLC purity verification included with every vial. Semaglutide is available on the semaglutide research vial page and tirzepatide on the tirzepatide research vial page; sourcing checklists specific to each compound are covered in where to buy semaglutide and where to buy tirzepatide.
Research Use Only. Semaglutide and tirzepatide are supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose, and not as a substitute for any prescription medication. This article is research education, not usage guidance, and references brand names solely for identification purposes; V8 Peptides is not affiliated with Novo Nordisk or Eli Lilly.